These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25841232)

  • 1. HFE gene mutation and oxidative damage biomarkers in patients with myelodysplastic syndromes and its relation to transfusional iron overload: an observational cross-sectional study.
    De Souza GF; Ribeiro HL; De Sousa JC; Heredia FF; De Freitas RM; Martins MR; Gonçalves RP; Pinheiro RF; Magalhães SM
    BMJ Open; 2015 Apr; 5(4):e006048. PubMed ID: 25841232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on HFE gene mutations in patients with myelodysplastic syndromes and aplastic anemia].
    Nie L; Ai XF; Zheng YZ; Li QH; Yang L; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):223-8. PubMed ID: 19731820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HFE genotype and iron metabolism in Chinese patients with myelodysplastic syndromes and aplastic anemia.
    Nie L; Li L; Yang L; Zhang Y; Xiao Z
    Ann Hematol; 2010 Dec; 89(12):1249-53. PubMed ID: 20563578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemochromatosis-associated gene mutations in patients with myelodysplastic syndromes with refractory anemia with ringed sideroblasts.
    Nearman ZP; Szpurka H; Serio B; Warshawksy I; Theil K; Lichtin A; Sekeres MA; Maciejewski JP
    Am J Hematol; 2007 Dec; 82(12):1076-9. PubMed ID: 17654685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of the H63D mutation of the HFE in north India: its presence does not cause iron overload in beta thalassemia trait.
    Garewal G; Das R; Ahluwalia J; Marwaha RK
    Eur J Haematol; 2005 Apr; 74(4):333-6. PubMed ID: 15777346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of C282Y, H63D, and S65C mutations in hereditary HFE-hemochromatosis gene in Lithuanian population.
    Kucinskas L; Juzenas S; Sventoraityte J; Cedaviciute R; Vitkauskiene A; Kalibatas V; Kondrackiene J; Kupcinskas L
    Ann Hematol; 2012 Apr; 91(4):491-5. PubMed ID: 21947086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of hemochromatosis mutations on iron overload of thalassemia major.
    Longo F; Zecchina G; Sbaiz L; Fischer R; Piga A; Camaschella C
    Haematologica; 1999 Sep; 84(9):799-803. PubMed ID: 10477452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of the hemochromatosis genetic variants in multiple myeloma in comparison to that of myelodysplastic syndrome.
    Várkonyi J; Demeter J; Tordai A; Andrikovics H
    Ann Hematol; 2006 Dec; 85(12):869-71. PubMed ID: 17001480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron overload in kidney transplants: prospective analysis of biochemical and genetic markers.
    Lorenz M; Kletzmayr J; Huber A; Hörl WH; Sunder-Plassmann G; Födinger M
    Kidney Int; 2005 Feb; 67(2):691-7. PubMed ID: 15673318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between HFE mutations and mild iron-overload expression.
    Mura C; Le Gac G; Raguénes O; Mercier AY; Le Guen A; Férec C
    Mol Genet Metab; 2000 Apr; 69(4):295-301. PubMed ID: 10870847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative imbalance in low/intermediate-1-risk myelodysplastic syndrome patients: The influence of iron overload.
    Ivars D; Orero MT; Javier K; Díaz-Vico L; García-Giménez JL; Mena S; Tormos C; Egea M; Pérez PL; Arrizabalaga B; Ruiz MÁ; Yagüe N; Tormo M; Sancho-Tello R; Gomes A; Algueró C; O'Connor JE; Sáez GT; Carbonell F; Collado R
    Clin Biochem; 2017 Nov; 50(16-17):911-917. PubMed ID: 28571970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HFE gene mutations in Tunisian major beta-Thalassemia and iron overload].
    Mellouli F; El Borgi W; Kaabi H; Ben Hassen E; Sassi R; Hmida H; Cherif G; Maamar M; Zouari B; Boukef K; Bejaoui M; Hmida S
    Transfus Clin Biol; 2006 Dec; 13(6):353-7. PubMed ID: 17303462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and clinical expression of HFE gene mutations in a Spanish population of subjects with abnormal iron metabolism.
    Gómez-Llorente C; Miranda-León MT; Blanco S; Gandia-Pla S; Gómez-Capilla JA; Fárez-Vidal ME
    Ann Hematol; 2005 Oct; 84(10):650-5. PubMed ID: 15986199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron status and HFE genotype in erythrocyte pyruvate kinase deficiency: study of Italian cases.
    Zanella A; Bianchi P; Iurlo A; Boschetti C; Taioli E; Vercellati C; Zappa M; Fermo E; Tavazzi D; Sampietro M
    Blood Cells Mol Dis; 2001; 27(3):653-61. PubMed ID: 11482880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of HFE mutations among the Thai population and correlation with iron loading in haemoglobin E disorder.
    Viprakasit V; Vathesathokit P; Chinchang W; Tachavanich K; Pung-Amritt P; Wimhurst VL; Yenchitsomanus PT; Merryweather-Clarke AT; Tanphaichitr VS
    Eur J Haematol; 2004 Jul; 73(1):43-9. PubMed ID: 15182337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary hemochromatosis in a Brazilian university hospital in São Paulo State (1990-2000).
    Martinelli AL; Filho R; Cruz S; Franco R; Tavella M; Secaf M; Ramalho L; Zucoloto S; Rodrigues S; Zago M
    Genet Mol Res; 2005 Mar; 4(1):31-8. PubMed ID: 15841433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
    Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic iron loading in patients with compound heterozygous HFE mutations.
    Lim EM; Rossi E; De Boer WB; Reed WD; Jeffrey GP
    Liver Int; 2004 Dec; 24(6):631-6. PubMed ID: 15566515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HFE gene mutations in Polish patients with disturbances of iron metabolism: an initial assessment.
    Sikorska K; Bielawski KP; Stalke P; Lakomy EA; Michalska Z; Witczak-Malinowska K; Romanowski T
    Int J Mol Med; 2005 Dec; 16(6):1151-6. PubMed ID: 16273299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.